Sanofi Pasteur gets additional order from US government to produce Influenza A Vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced that the company has received an additional order from the US Department of Health and Human Services (HHS) to produce vaccine to help protect against the Influenza A (H1N1) 2009 virus. The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 mcg of antigen per dose.

Specifications for formulation and filling of this new bulk order will be the subject of a separate order. To date, Sanofi Pasteur has committed to the US government a total of 75.3 million doses of Influenza A (H1N1) 2009 Monovalent Vaccine.

Comments

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying